Immature neoplastic cells of cervical intraepithelial neoplasia (CIN) in formaldehyde-fixed sections of human cervix possess guanidinobenzoatase (GB) activity, which can be located with fluorescent probes for the active centre of this enzyme [ I ] . In the process of normal epithelial cell maturation, the activity of cell-surfce GB decreases to an undetectable level 111. When such cells detach from the cervix, GB activity on these immature cells should still be detectable if the cells are spread on a glass slide in the form of a smear. Millions of such cervical smears are prepared each year for the routine histological screening for cells from CIN. We describe a simple fluorescent technique for the rapid location of epithelial cells containing GB, since these cells are also likely to be of interest in cervical screening.
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The rationale for this technique is based upon three observations. Frist, GB binds 9-aminoacridine (9-AA) [ 21 and this complex can subsequently bind propidium iodide (PI), resulting in a red-orange fluorescence of the cell surface [ 11. Secondly, all smears are heavily contaminated with bacteria and inflammatory cells which also bind 9-AA; these cell types have to be excluded from the final fluorescent analysis by selective quenching. Quenching is achieved with a nuclear stain, haematoxylin, which when close to the cell surface causes quenching of surface fluorescence in inflammatory cells. Thirdly, the vaginal fluid contains protein inhibitors of GB [3] which may be displaced by formaldehyde treatment 131. We take advantage of this naturally occurring enzyme-inhibitor complex to protect the active centre of the GB on these epithelial cells during the acidic haematoxylin nuclear staining step. The inhibitor is later Abbreviations used: CIN, cervical intraepithelial neoplasia; GB, guanidinobenzoatase; 9-AA. 9-aminoacridine; PI, propidium iodide.
released and the re-activated G B located with 9-AA plus PI for increased fluourescent contrast.
The staining procedure is as follows. The air-dried smears are placed in Meyer's haematoxylin solution for I min, then rinsed free of excess reagent in a bath of saline (150 mMNaCI). The haematoxylin-treated smears are then placed in 10% (v/v) formaldehyde in saline for 1 h to displace inhibitor from cell-bound GB. The smears are then placed in saline containing M+AA and M-NaHCO, with a pH of 8.4 for 5 min. The smears are then placed in an identical 9-AA solution but with the inclusion of M-PI for 2 min. Finally, the smears are rinsed in saline for 30 s and examined by fluorescent microscopy. We used either a Leitz Orthoplan microscope with a range of filters or a Leitz Diaplan with filter cubes [GI or [N] to locate the GB-containing cells which fluoresce strongly; cells lacking this enzyme do not fluoresce. The bacteria and small inflammatry cells lack fluorescence, due to quenching; this step makes the whole process of locating GB-containing epithelial cells that much easier.
We know from studies on other tissue sections that GB activity is associated with tumour cells [2, 4, 5] and with cells from CIN [ 11. We hope that the location of similar cells in the cervical smears will be of value in the search for a more satisfactory screening procedure in the future. have M, values of approx. 70 000; both enzymes are trypsinlike and show a marked selectivity for arginyl peptide bonds.
The active site titrants, nitrophenyl-p-guanidinobenzoate [6] and methylumbelliferyl-p-guanidinobenzoate (MUGB) [7], were designed as suicidal stoichiometric inhibitors for trypsin-like enzymes. GB acts on both these guanidinobenzoates as if they were substrates rather than active-site titrants. A similar observation has been made for SCTPA with respect to MUGB IS]. MUGB therefore distinguishes SCTPA and GB from other trypsin-like enzymes, on which MUGB acts like a suicide substrate. Bis (N-benzyloxycarbonyl-L-argininamid0)-rhodamine (BZAR) was designed as a fluorogenic substrate for trypsinlike enzymes [8] . BZAR has been shown to inhibit GB, M causing 50% inhibition of G B when assayed with MUGB [9] as substrate. BZAR also inhibits SCTPA when assayed with its peptide substrate S-2288 (Kabi), 2 x M-BZAR causing 50% inhibition of SCTPA.
